Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1072155.RAd6dw7TVAaCJ6CHNGYPkuNvkNrqi84JgT0WPFu3AFhjg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1072155.RAd6dw7TVAaCJ6CHNGYPkuNvkNrqi84JgT0WPFu3AFhjg130_assertion type Assertion NP1072155.RAd6dw7TVAaCJ6CHNGYPkuNvkNrqi84JgT0WPFu3AFhjg130_head.
- NP1072155.RAd6dw7TVAaCJ6CHNGYPkuNvkNrqi84JgT0WPFu3AFhjg130_assertion wasGeneratedBy ECO_0000203 NP1072155.RAd6dw7TVAaCJ6CHNGYPkuNvkNrqi84JgT0WPFu3AFhjg130_provenance.
- NP1072155.RAd6dw7TVAaCJ6CHNGYPkuNvkNrqi84JgT0WPFu3AFhjg130_assertion wasDerivedFrom befree-2016 NP1072155.RAd6dw7TVAaCJ6CHNGYPkuNvkNrqi84JgT0WPFu3AFhjg130_provenance.
- NP1072155.RAd6dw7TVAaCJ6CHNGYPkuNvkNrqi84JgT0WPFu3AFhjg130_assertion SIO_000772 23616623 NP1072155.RAd6dw7TVAaCJ6CHNGYPkuNvkNrqi84JgT0WPFu3AFhjg130_provenance.
- NP1072155.RAd6dw7TVAaCJ6CHNGYPkuNvkNrqi84JgT0WPFu3AFhjg130_assertion evidence source_evidence_literature NP1072155.RAd6dw7TVAaCJ6CHNGYPkuNvkNrqi84JgT0WPFu3AFhjg130_provenance.
- NP1072155.RAd6dw7TVAaCJ6CHNGYPkuNvkNrqi84JgT0WPFu3AFhjg130_assertion description "[The activation of B-cell-specific genes, such as CD19 and PAX5, is a hallmark of t(8;21) acute myeloid leukemia (AML) which expresses the translocation product RUNX1/ETO.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1072155.RAd6dw7TVAaCJ6CHNGYPkuNvkNrqi84JgT0WPFu3AFhjg130_provenance.